Zentalis Pharma FY EPS $(4.47) Up From $(4.48) YoY; Cash Balance Of $483M, With Projected Cash Runway Into 2026
Company Profile
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.